Back
Ligand Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
LGND
Ligand Pharmaceuticals, Inc.
Last Price:
$199.45
Seasonality Move:
10.32%
7 Day Trial
ALL ACCESS PASS
$
7
Ligand Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 18.2% based on the past 31 years of stock performance.
-
Ligand Pharmaceuticals, Inc. has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
-
Is Ligand Pharmaceuticals, Inc. Stock Undervalued?The current Ligand Pharmaceuticals, Inc. [LGND] share price is $200.33. The Score for LGND is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Ligand Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 18.2% based on the past 31 years of stock performance.
Ligand Pharmaceuticals, Inc. Stock Rating
Buy
59
Ligand Pharmaceuticals, Inc. (LGND)
is a Buy
Is Ligand Pharmaceuticals, Inc. overpriced?
-
Ligand Pharmaceuticals, Inc. has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
Ligand Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ligand.com
52-Week Data
52-Week High:
212.49
52-Week Low:
93.58
Prediction Charts
Market Cap:
3.9B
Price in USD:
200.33
Volume:
427.4K
Beta:
1.45
Technical Analysis
SMA50:
193.24
SMA100:
177.73
SMA200:
144.60
52-Wk Change:
75.81%
Stock Predictions
-
Is Ligand Pharmaceuticals, Inc. stock public?Yes, Ligand Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Ligand Pharmaceuticals, Inc. stock quote today?The Ligand Pharmaceuticals, Inc. stock price is 200.33 USD today.
-
How to buy Ligand Pharmaceuticals, Inc. stock online?You can buy Ligand Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 196.97 | 195.10 | 201.49 | 194.21 |
| Dec-3 | 196.94 | 193.03 | 197.00 | 191.27 |
| Dec-4 | 192.75 | 188.50 | 194.90 | 187.87 |
| Dec-5 | 188.58 | 184.87 | 189.46 | 184.22 |
| Dec-8 | 186.70 | 184.71 | 189.76 | 183.23 |
| Dec-9 | 189.29 | 185.83 | 192.44 | 185.23 |
| Dec-10 | 187.77 | 184.03 | 188.54 | 183.44 |
| Dec-11 | 185.93 | 183.13 | 186.63 | 179.65 |
| Dec-12 | 183.30 | 189.55 | 190.28 | 181.68 |
| Dec-15 | 190.44 | 193.04 | 194.89 | 190.44 |
| Dec-16 | 191.68 | 192.63 | 196.00 | 188.69 |
| Dec-17 | 192.50 | 194.53 | 196.00 | 189.03 |
| Dec-18 | 195.03 | 198.41 | 200.00 | 194.00 |
| Dec-19 | 197.87 | 200.33 | 202.50 | 197.81 |
Ligand Pharmaceuticals, Inc. Earnings
Ligand Pharmaceuticals, Inc. Earnings Report: Per Share Ligand Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ligand Pharmaceuticals, Inc. Forecast Revenue Growth
Ligand Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and an increase next year of $0.84 per share.
* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.